Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study

Clinical studies indicate that patients with acute schizophrenia may benefit from benzodiazepine treatment. Therefore we investigated the benzodiazepine receptor distribution and diazepam binding in 20 patients with DSM-III schizophrenia using single photon emission computed tomography (SPECT) with...

Full description

Saved in:
Bibliographic Details
Main Authors: Schröder, Johannes (Author) , Bubeck, Bernd (Author) , Demisch, Sibylle (Author) , Sauer, Heinrich (Author)
Format: Article (Journal)
Language:English
Published: 1997
In: Psychiatry research
Year: 1997, Volume: 68, Issue: 2, Pages: 125-131
ISSN:1872-7123
DOI:10.1016/S0925-4927(96)02843-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0925-4927(96)02843-0
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0925492796028430
Get full text
Author Notes:Johannes Schröder, Bernd Bubeck, Sibylle Demisch, Heinrich Sauer
Description
Summary:Clinical studies indicate that patients with acute schizophrenia may benefit from benzodiazepine treatment. Therefore we investigated the benzodiazepine receptor distribution and diazepam binding in 20 patients with DSM-III schizophrenia using single photon emission computed tomography (SPECT) with iomazenil as the ligand. In each patient, two SPECT images were obtained: SPECT 1 was obtained 2 h after intravenous injection of 200 MBq I-123-iomazenil. Following SPECT 1, patients received 10 mg diazepam intravenously. Twenty min later, SPECT 2 was started. The highest iomazenil uptake was found in the occipital cortex followed by the frontal and temporal cortices. Baseline iomazenil uptake in the medial frontal cortex was significantly (P < 0.05) correlated with the BPRS total score (r = 0.46). Diazepam injection led to a significant activity decrease in iomazenil binding which was greatest in the frontal regions of interest. With respect to the medial frontal cortex, this effect was significantly (P < 0.05) more pronounced in patients with a remitting than a chronic course of the disorder. These findings suggest that changes of the benzodiazepine receptor system in the frontal cortex may be associated with severity and chronicity of schizophrenia.
Item Description:Elektronische Reproduktion der Druck-Ausgabe 25. März 1999
Gesehen am 09.12.2021
Physical Description:Online Resource
ISSN:1872-7123
DOI:10.1016/S0925-4927(96)02843-0